Related Experiment Videos
Paraaortic lymph node irradiation in cervical carcinoma without prior lymphadenectomy
Radiology
|July 1, 1987
Summary
Paraaortic irradiation for uterine cervical cancer is safe and well-tolerated in selected patients without prior lymphadenectomy. This treatment showed no major complications and offered a 38% disease-free survival rate, indicating its potential utility.
Area of Science:
- Oncology
- Radiation Oncology
- Gynecologic Oncology
Background:
- Uterine cervical cancer treatment often involves radiation therapy.
- Paraaortic lymph node involvement is a critical prognostic factor.
- Prior lymphadenectomy can influence subsequent radiation treatment planning and toxicity.
Purpose of the Study:
- To evaluate the complications associated with paraaortic irradiation.
- To assess the safety and efficacy of paraaortic irradiation in cervical cancer patients.
- To determine the rate of disease recurrence after paraaortic irradiation in a selected patient cohort.
Main Methods:
- Retrospective study of 29 cervical cancer patients treated between 1975-1984.
- Patients received paraaortic irradiation as part of definitive treatment without prior lymphadenectomy.
- Radiation doses ranged from 4,200-5,000 rad (42-50 Gy) using an anteroposterior-posteroanterior technique.
Main Results:
- No instances of small-bowel obstruction or other major complications were observed.
- No surgical procedures or deaths were attributed to paraaortic irradiation.
- Eleven patients (38%) remained disease-free 23-120 months post-therapy.
Conclusions:
- Paraaortic irradiation was well-tolerated in this selected group of patients.
- The technique demonstrated relative safety when used in conjunction with appropriate methods.
- Paraaortic irradiation may be a viable treatment option for select cervical cancer patients.